v3.20.2
Consolidated Balance Sheets - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Current Assets    
Cash and cash equivalents $ 20,668,241 $ 9,039,887
Short-term investments 26,312,039 5,713,922
Accounts receivable 26,967 34,986
Prepaid expenses and other current assets 593,924 420,328
Total Current Assets 47,601,171 15,209,123
Property and Equipment, net 669,401 559,410
Other Assets    
In-process R&D 5,866,000 5,866,000
Goodwill 1,452,338 1,452,338
Operating lease right-of-use asset 2,134,573 2,287,500
Finance lease right-of-use asset 306,643 187,573
Deposits 122,905 394,637
Total Other Assets 9,882,459 10,188,048
Total Assets 58,153,031 25,956,581
Current Liabilities    
Accounts payable 779,642 1,503,342
Deferred revenue, current portion 1,915,924 3,410,319
Contingent consideration, current portion 1,531,636 1,124,970
Contingent consideration, related party - current portion 454,364 454,364
Operating lease liability, current portion 228,776 216,832
Finance lease liability, current portion 104,828 49,104
Accrued expenses and other liabilities 1,202,705 1,676,467
Total Current Liabilities 6,217,875 8,435,398
Long Term Liabilities    
Other long-term liabilities 22,847  
Derivative warrant liability 47,939  
Deferred tax liability 361,911 361,911
Deferred revenue, net of current portion 200,000 200,000
Operating lease liability, net of current portion 1,402,962 1,519,574
Financing lease liability, net of current portion 215,112 142,667
Contingent consideration, net of current portion 1,969,538 1,653,197
Contingent consideration, related party - net of current portion 578,977 485,984
Total Liabilities 11,017,161 12,798,731
Commitments and Contingencies (Note 9 and 13)
Stockholders' Equity    
Common stock, $.0002 par value; 250,000,000 shares authorized, 110,023,783 and 33,785,999 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively 22,006 6,757
Additional paid-in capital 163,007,558 118,173,843
Accumulated deficit (115,344,284) (104,597,748)
Accumulated other comprehensive income (loss) 28,044 (11,250)
Total Stockholders' Equity - Heat Biologics, Inc. 47,713,324 13,571,602
Non-Controlling Interest (577,454) (413,752)
Total Stockholders' Equity 47,135,870 13,157,850
Total Liabilities and Stockholders' Equity $ 58,153,031 $ 25,956,581

Source